Seven Eight Capital’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-10,606
Closed -$461K 651
2021
Q4
$461K Buy
+10,606
New +$416K 0.08% 285
2021
Q3
Sell
-4,970
Closed -$210K 688
2021
Q2
$210K Buy
+4,970
New +$193K 0.03% 552
2020
Q4
Sell
-36,300
Closed -$911K 566
2020
Q3
$911K Buy
+36,300
New +$529K 0.2% 192
2016
Q3
Sell
-1,500
Closed -$56K 492
2016
Q2
$56K Buy
+1,500
New +$56.4K 0.02% 445
2016
Q1
Sell
-2,900
Closed -$104K 646
2015
Q4
$104K Buy
+2,900
New +$105K 0.07% 340

Other funds holding ACH

Seven Eight Capital's ACH Position: Q1 2022 in Review

Seven Eight Capital sold out of Accendra Health (ACH) in Q1 2022, closing a stake of 10,606 shares — an estimated $461K sold.

Seven Eight Capital first reported a position in ACH in Q4 2015 and held it in 5 quarters. The position peaked at $911K in Q3 2020. 266 funds tracked by Wall St. Rank hold ACH as of Q1 2022.

  • Seven Eight Capital reported no remaining Accendra Health position as of Q1 2022 after selling out during the quarter.
  • Seven Eight Capital sold 10,606 Accendra Health shares in Q1 2022, an estimated $461K.
  • Seven Eight Capital first reported a position in Accendra Health in Q4 2015 and held it in 5 quarters.
  • Seven Eight Capital's Accendra Health position peaked at $911K in Q3 2020.
  • 266 funds tracked by Wall St. Rank held Accendra Health as of Q1 2022.

Based on Seven Eight Capital's 13F filing for Q1 2022, filed 11 May 2022.